Loading clinical trials...
Loading clinical trials...
Phase 2b, Multicenter Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
Conditions
Interventions
BC-819/PEI
Locations
6
United States
BCG Oncology
Phoenix, Arizona, United States
Bnai Zion Medical Center
Haifa, Israel
Edith Wolfson Medical Center
Holon, Israel
Hadassah and Hebrew University Medical Center
Jerusalem, Israel
Meir Medical Center
Kfar Saba, Israel
Assaf Harofeh
Zrifin, Israel
Start Date
January 1, 2008
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
April 30, 2019
NCT02773849
NCT05084586
NCT00322699
Lead Sponsor
Anchiano Therapeutics Israel Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions